Biotech And Pharma Stocks Rally On Positive Profit And Trial News

Biotech and pharma stocks experienced a surge due to positive earnings reports and promising obesity drug trial results, leading to increased trading volumes. Wave Life Sciences' obesity treatment data showed weight loss comparable to GLP-1 drugs with less muscle loss risk, causing a 140% stock jump, while Structure Therapeutics' aleniglipron drug also met key trial milestones.